Fundraising FoxAxil Capital — Full Portfolio
5 tracked investments · listed companies and verified rows first
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.
BiotechDeep TechHealthtechLongevity
Co-investorsAsahi Kasei Corporate Venture CapitalFast Track InitiativeRemiges Ventures, Inc.4BIO CapitalAstellas Venture Management LLCDCI Partners Co. Ltd.
MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use.
BiotechDeep TechHealthtech
Co-investorsBeyond Next VenturesLong Black Partners
BiotechMedford, US
Giovanni Traverso(Director)inRobert Langer(Director)Carl Schoellhammer(Executive Officer, Director)inAmy Schulman(Director)
Co-investorsTaiwania Capital
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsNextLeap VenturesHelios Climate Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.